Pharmaceuticals company FDC announced Q2FY27 results Consolidated Financial Highlights: Revenue from Operations: For Q2FY27, revenue from operations stood at Rs 57,214 lakh, indicating a QoQ decrease of 14.31% relative to Rs 66,769 lakh in Q1FY27, and a YoY increase of 20.95% relative to Rs 47,303 lakh in Q2FY26. For H1FY27, it stood at Rs 1,23,983 lakh, registering a YoY expansion of 10.56% against Rs 1,12,144 lakh in H1FY26. Total Income: For Q2FY27, total income reached Rs 59,008 lakh, lower by 17.51% QoQ compared to Rs 71,535 lakh in Q1FY27, and higher by 19.53% YoY compared to Rs 49,366 lakh in Q2FY26. For H1FY27, total income reached Rs 1,30,311 lakh, up 10.80% YoY from Rs 1,17,613 lakh in H1FY26. Profit Before Tax (PBT): For Q2FY27, PBT was Rs 6,541 lakh, showing a QoQ drop of 62.56% from Rs 17,470 lakh in Q1FY27, and a YoY growth of 71.72% over Rs 3,809 lakh in Q2FY26. For H1FY27, PBT stood at Rs 24,011 lakh, an increase of 21.35% YoY relative to Rs 19,786 lakh in H1FY26. Profit After Tax (PAT): For Q2FY27, PAT arrived at Rs 4,906 lakh, a contraction of 62.97% QoQ from Rs 13,248 lakh in Q1FY27, but an expansion of 72.93% YoY from Rs 2,837 lakh in Q2FY26. For H1FY27, PAT was reported at Rs 18,155 lakh, advancing 21.26% YoY against Rs 14,972 lakh in H1FY26. Earnings Per Share (EPS): For Q2FY27, basic and diluted EPS was Rs 3.01, down 63.02% QoQ against Rs 8.14 in Q1FY27, and up 72.00% YoY against Rs 1.75 in Q2FY26. For H1FY27, EPS reached Rs 11.15, presenting a YoY expansion of 21.20% compared to Rs 9.20 in H1FY26. Standalone Financial Highlights: Revenue from Operations: For Q2FY27, standalone revenue from operations stood at Rs 55,279 lakh, marking a QoQ drop of 15.62% from Rs 65,510 lakh in Q1FY27, and a YoY growth of 19.72% from Rs 46,174 lakh in Q2FY26. For H1FY27, it stood at Rs 1,20,789 lakh, gaining 9.41% YoY compared to Rs 1,10,402 lakh in H1FY26. Total Income: For Q2FY27, standalone total income was Rs 57,141 lakh, which is 18.66% lower QoQ over Rs 70,244 lakh in Q1FY27, and 18.39% higher YoY over Rs 48,265 lakh in Q2FY26. For H1FY27, standalone total income achieved Rs 1,27,153 lakh, rising 9.70% YoY from Rs 1,15,909 lakh in H1FY26. Profit Before Tax (PBT): For Q2FY27, standalone PBT recorded Rs 6,353 lakh, down 63.55% QoQ against Rs 17,427 lakh in Q1FY27, and up 60.88% YoY against Rs 3,949 lakh in Q2FY26. For H1FY27, standalone PBT reached Rs 23,781 lakh, achieving an 18.68% YoY growth relative to Rs 20,038 lakh in H1FY26. Profit After Tax (PAT): For Q2FY27, standalone PAT stood at Rs 4,769 lakh, reducing 63.88% QoQ compared to Rs 13,202 lakh in Q1FY27, but increasing 61.77% YoY compared to Rs 2,948 lakh in Q2FY26. For H1FY27, standalone PAT was Rs 17,971 lakh, up 18.49% YoY from Rs 15,167 lakh in H1FY26. Earnings Per Share (EPS): For Q2FY27, standalone basic and diluted EPS was Rs 2.93, changing by -63.87% QoQ from Rs 8.11 in Q1FY27, and by +61.88% YoY from Rs 1.81 in Q2FY26. For H1FY27, standalone EPS was Rs 11.04, expanding 18.45% YoY relative to Rs 9.32 in H1FY26. Result PDF